# Evaluation of RTVue XR With SSADA

> **NCT02535520** · — · COMPLETED · sponsor: **Optovue** · enrollment: 155 (actual)

## Conditions studied

- Retina Vascular Pathology

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02535520
- **Lead sponsor:** Optovue
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2016-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02535520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02535520, "Evaluation of RTVue XR With SSADA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02535520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*